Modelling NAFLD disease burden in four Asian regions—2019‐2030
Alimentary Pharmacology & Therapeutics2020Vol. 51(8), pp. 801–811
Citations Over TimeTop 1% of 2020 papers
Chris Estes, Henry Lik‐Yuen Chan, Rong‐Nan Chien, Wan‐Long Chuang, James Fung, George Boon‐Bee Goh, Tsung H. Hu, Jee‐Fu Huang, Byoung Kuk Jang, Dae Won Jun, Jia‐Horng Kao, Jin‐Woo Lee, Han‐Chieh Lin, Kathryn Razavi‐Shearer, Wai‐Kay Seto, Grace Lai–Hung Wong, Vincent Wai‐Sun Wong, Homie Razavi
Abstract
Preventing the growth of diabetic and obese populations will be a key factor in reducing ongoing increases in NAFLD-related disease burden in the Asia-Pacific region.
Related Papers
- → Review article: is non‐alcoholic fatty liver disease a spectrum, or are steatosis and non‐alcoholic steatohepatitis distinct conditions?(2012)215 cited
- → Prevalence of fatty liver in metabolic syndrome(2020)16 cited
- → Non-alcoholic steatohepatitis(2006)15 cited
- → Categorization and complication of non-alcoholic fatty liver disease(2022)1 cited
- → Mo1015 Liver Function Breath Tests for Differentiation of Steatohepatitis From Simple Fatty Liver in Patients With Non-Alcoholic Fatty Liver Disease(2013)